SynBioBeta Speaker
Robert-Jan de Voogd
Corbion
General Manager
During the last 5 years I have focused on scaling novel ingredients, such as our micro algae business, from scale up to globally adopted ingredients. Our algae omega 3 portfolio has been a testament of that, where we went from novel ingredient to the largest (single) producer of omega 3s in the world. We're now developing new fermentation based ingredients to expand our portfolio in nutrition and natural preservation. We're looking to do this either inhouse or in collaboration with others.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Robert-Jan
This Year
Session lineup still growing
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Featuring
Speaker Coming Soon
